Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference

Rhea-AI Summary

Haemonetics Corporation (NYSE: HAE) has announced that President and CEO Chris Simon will participate in a fireside chat with investors at the Goldman Sachs 46th Annual Global Healthcare Conference. The event is scheduled for Monday, June 9, 2025, at 8:40 a.m. ET. Investors and the public can access the live webcast through Haemonetics' Investor Relations website or via a provided direct link. A replay of the webcast will be made available 12 hours after the event and will remain accessible for 90 days on the company's Investor Relations website.

News Market Reaction – HAE

-0.19%

-0.19% Session move

In the trading session that priced this news, HAE declined 0.19%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BOSTON, May 30, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025 at 8:40 a.m. ET.

The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at the following link: https://event.webcasts.com/starthere.jsp?ei=1721260&tp_key=3096fdc651&tp_special=8

A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website.

ABOUT HAEMONETICS

Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:     
Olga Guyette, Vice President-Investor Relations & Treasury     
(781) 356-9763   
olga.guyette@haemonetics.com 

David Trenk, Manager-Investor Relations
(203) 733-4987
david.trenk@haemonetics.com                                                                               

Media Contact:       
Josh Gitelson, Sr. Director-Global Communications   
(781) 356-9776
josh.gitelson@haemonetics.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-goldman-sachs-46th-annual-global-healthcare-conference-302468741.html

SOURCE Haemonetics Corporation

FAQ

When is Haemonetics (HAE) presenting at the Goldman Sachs Healthcare Conference 2025?

Haemonetics will present at the Goldman Sachs Healthcare Conference on Monday, June 9, 2025 at 8:40 a.m. ET.

Who will represent Haemonetics (HAE) at the Goldman Sachs Healthcare Conference?

Chris Simon, President and CEO of Haemonetics, will represent the company at the conference.

How can investors access Haemonetics' (HAE) presentation at the Goldman Sachs conference?

Investors can access the live webcast through Haemonetics' Investor Relations website or via a provided direct link.

How long will the replay of Haemonetics' (HAE) Goldman Sachs conference presentation be available?

The replay will be available for 90 days on Haemonetics' Investor Relations website, accessible 12 hours after the event.